Pchitskaya EI et al. |
Dynamic Microtubules in Alzheimer's Disease: Association with Dendritic Spine Pathology. |
2018 |
Biochemistry Mosc. |
pmid:30472945
|
Woods LM et al. |
Synthesis and Biological Evaluation of 7-Deoxy-Epothilone Analogues. |
2017 |
Int J Mol Sci |
pmid:28304361
|
Haydl AM and Breit B |
The Total Synthesis of Epothilone D as a Yardstick for Probing New Methodologies. |
2017 |
Chemistry |
pmid:27792853
|
Penazzi L et al. |
Aβ-mediated spine changes in the hippocampus are microtubule-dependent and can be reversed by a subnanomolar concentration of the microtubule-stabilizing agent epothilone D. |
2016 |
Neuropharmacology |
pmid:26772969
|
Bakota L and Brandt R |
Tau Biology and Tau-Directed Therapies for Alzheimer's Disease. |
2016 |
Drugs |
pmid:26729186
|
Killinger BA and Moszczynska A |
Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers. |
2016 |
J. Neurochem. |
pmid:26465779
|
Ye W et al. |
A new approach for improving epothilone B yield in Sorangium cellulosum by the introduction of vgb epoF genes. |
2016 |
J. Ind. Microbiol. Biotechnol. |
pmid:26803504
|
Burrell RC et al. |
Synthesis of stable isotope-labeled epothilone D using a degradation-reconstruction approach. |
2015 |
J Labelled Comp Radiopharm |
pmid:26158758
|
Brizuela M et al. |
The microtubule-stabilizing drug Epothilone D increases axonal sprouting following transection injury in vitro. |
2015 |
Mol. Cell. Neurosci. |
pmid:25684676
|
Yuan L et al. |
Use of a carboxylesterase inhibitor of phenylmethanesulfonyl fluoride to stabilize epothilone D in rat plasma for a validated UHPLC-MS/MS assay. |
2014 |
J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. |
pmid:25151331
|
Xiong Y et al. |
HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:23487739
|
Cartelli D et al. |
Microtubule alterations occur early in experimental parkinsonism and the microtubule stabilizer epothilone D is neuroprotective. |
2013 |
Sci Rep |
pmid:23670541
|
Wang C et al. |
Molybdenum-based complexes with two aryloxides and a pentafluoroimido ligand: catalysts for efficient Z-selective synthesis of a macrocyclic trisubstituted alkene by ring-closing metathesis. |
2013 |
Angew. Chem. Int. Ed. Engl. |
pmid:23307513
|
Wessjohann LA et al. |
Total synthesis of epothilone D: the nerol/macroaldolization approach. |
2013 |
J. Org. Chem. |
pmid:24079664
|
Sang F et al. |
Epothilone D and its 9-Methyl analogues: combinatorial syntheses, conformation, and biological activities. |
2013 |
Eur J Med Chem |
pmid:23994325
|
Brunden KR et al. |
MT-Stabilizer, Dictyostatin, Exhibits Prolonged Brain Retention and Activity: Potential Therapeutic Implications. |
2013 |
ACS Med Chem Lett |
pmid:24900764
|
Barten DM et al. |
Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027. |
2012 |
J. Neurosci. |
pmid:22623658
|
Brunden KR et al. |
Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies. |
2012 |
Biochem. Soc. Trans. |
pmid:22817712
|
Zhang B et al. |
The microtubule-stabilizing agent, epothilone D, reduces axonal dysfunction, neurotoxicity, cognitive deficits, and Alzheimer-like pathology in an interventional study with aged tau transgenic mice. |
2012 |
J. Neurosci. |
pmid:22423084
|
Fournet V et al. |
Both chronic treatments by epothilone D and fluoxetine increase the short-term memory and differentially alter the mood status of STOP/MAP6 KO mice. |
2012 |
J. Neurochem. |
pmid:23013328
|